IP Library Granted Patent US 11,473,001
Granted Patent B2
US 11,473,001 · App. 16/745,422 · Granted Oct 18, 2022

Delivery of halogens to a subterranean formation

Inventors: Desmond Schipper (Houston, TX); Katherine Leigh Hull (Houston, TX); Younane N. Abousleiman (Norman, OK)
Assignee: Saudi Arabian Oil Company
C09K8/524C09K8/536
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,473,001
App. No.
16/745,422
Granted
Oct 18, 2022
Kind
B2
Abstract

Compositions and methods for treating kerogen in a subterranean formation by generating bromine and other halogens in situ in a subterranean formation. In some implementations, the generation of the bromine or halogen is delayed. This can occur, for example, by the decomposition of precursors, a chemical reaction, the encapsulation of precursors or reactants, or a combination of these approaches.

Claims (22)

1. A composition for treating kerogen in a subterranean formation, comprising:

at least one of a bromate or chlorate salt, wherein the bromate or chlorate salt is encapsulated in a first polymer, and wherein the bromate or chlorate salt comprises a cation comprising a fluorine-carbon bond; and

an acid, wherein the acid is lactic acid, polylactic acid, chloracetic acid, citric acid, benzoic acid, or furoic acid.

2. The composition of claim 1 , wherein the first polymer is a polymer matrix selected from a group consisting of polyvinyl butyral polymer, vinyl acetal polymers, butyral polymers, sytrene/-maleic anhydride copolymers, and alkylated vinylpyrrolidone copolymers.

3. The composition of claim 1 , wherein the first polymer is an enteric coating and is selected from a group consisting of methylacrylate-methacrylic acid copolymers, cellulose acetate phthalate, cellulose acetate succinate, hydroxypropylmethyl cellulose phthalate, hypromellose acetate succinate, polyvinyl acetate phthalate, shellac, cellulose acetate trimellitate, sodium alginate, and zein.

4. The composition of claim 1 , wherein the acid is encapsulated in a second polymer, wherein the second polymer is a polymer matrix selected from a group consisting of polyvinyl butyral polymer, vinyl acetal polymers, butyral polymers, sytrene/-maleic anhydride copolymers, and alkylated vinylpyrrolidone copolymers.

5. The composition of claim 1 , wherein the acid is encapsulated in a second polymer, wherein the second polymer is an enteric coating selected from a group consisting of methylacrylate-methacrylic acid copolymers, cellulose acetate phthalate, cellulose acetate succinate, hydroxypropylmethyl cellulose phthalate, hypromellose acetate succinate, polyvinyl acetate phthalate, shellac, cellulose acetate trimellitate, sodium alginate, and zein.

6. The composition of claim 1 , further comprising a fracturing fluid.

7. The composition of claim 6 , wherein the fracturing fluid comprises a carbon dioxide based fluid or foam.

8. The composition of claim 7 , wherein the cation is selected from the group consisting of [P(CF 3 ) 4 ] + , [N(CF 3 ) 4 ] + , and bis(tri(4-fluorophenyl)phosphine)iminium.

9. The composition of claim 8 , wherein the first polymer is a polymer matrix selected from a group consisting of polyvinyl butyral polymer, vinyl acetal polymers, butyral polymers, sytrene/-maleic anhydride copolymers, and alkylated vinylpyrrolidone copolymers.

10. The composition of claim 6 , wherein the cation is selected from the group consisting of [P(CF 3 ) 4 ] + , [N(CF 3 ) 4 ] + , and bis(tri(4-fluorophenyl)phosphine)iminium.

11. The composition of claim 5 , wherein the cation is selected from the group consisting of [P(CF 3 ) 4 ] + , [N(CF 3 ) 4 ] + , and bis(tri(4-fluorophenyl)phosphine)iminium.

12. The composition of claim 10 , further comprising a fracturing fluid.

13. The composition of claim 4 , wherein the cation is selected from the group consisting of [P(CF 3 ) 4 ] + , [N(CF 3 ) 4 ] + , and bis(tri(4-fluorophenyl)phosphine)iminium.

14. The composition of claim 13 , further comprising a fracturing fluid.

15. The composition of claim 3 , wherein the cation is selected from the group consisting of [P(CF 3 ) 4 ] + , [N(CF 3 ) 4 ] + , and bis(tri(4-fluorophenyl)phosphine)iminium.

16. The composition of claim 15 , further comprising a fracturing fluid.

17. The composition of claim 2 , wherein the cation is selected from the group consisting of [P(CF 3 ) 4 ] + , [N(CF 3 ) 4 ] + , and bis(tri(4-fluorophenyl)phosphine)iminium.

18. The composition of claim 17 , further comprising a fracturing fluid.

19. The composition of claim 1 , wherein the cation is selected from the group consisting of [P(CF 3 ) 4 ] + , [N(CF 3 ) 4 ] + , and bis(tri(4-fluorophenyl)phosphine)iminium.

20. The composition of claim 19 , further comprising a fracturing fluid.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2020
From: ARAMCO SERVICES COMPANY
To: SAUDI ARAMCO UPSTREAM TECHNOLOGY COMPANY
Reel/Frame 052509/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2020
From: SAUDI ARAMCO UPSTREAM TECHNOLOGY COMPANY
To: SAUDI ARABIAN OIL COMPANY
Reel/Frame 052509/0399 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2020
From: SCHIPPER, DESMOND; HULL, KATHERINE LEIGH; ABOUSLEIMAN, YOUNANE N.
To: ARAMCO SERVICES COMPANY
Reel/Frame 051546/0431 →
Continuity (1)
Related Publication 20210222049A1 · Jul 22, 2021